Labshake search
Citations for R&D Systems :
751 - 800 of 1098 citations for 7 METHYLTHIENO 2 3 B QUINOLINE 2 CARBOXYLIC ACID since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Developmental Biology 2021Quote: ... 3 µM ZM306416 (R&D Systems, 2499/1) and 10 µM of SU5402 (R&D Systems ...
-
bioRxiv - Immunology 2021Quote: ... at 3 μM and necrosulfonamide (R&D systems) at 1 μM ...
-
bioRxiv - Genomics 2021Quote: ... or 3 ng/ml TGFB (R&D Systems), or both ...
-
bioRxiv - Immunology 2022Quote: ... anti-IFN-λ2-3 (MAB17892; R&D systems) and anti-IFNAR1 (BE00241 ...
-
bioRxiv - Neuroscience 2021Quote: ... goat anti-Galectin-3 (R&D Systems, AF1154), goat anti-GPNMB (R&D Systems ...
-
bioRxiv - Cancer Biology 2019Quote: ... and cleaved Caspase-3 (Asp175) (R&D Systems) was diluted 1:100 in EnVision Flex Antibody Diluent (Dako ...
-
bioRxiv - Immunology 2020Quote: ... at 3 μM and necrosulfonamide (R&D systems) at 1 μM ...
-
bioRxiv - Immunology 2020Quote: ... TGF-β (3 ng/ml, R&D Systems) and Retinoic Acid (RA ...
-
bioRxiv - Physiology 2022Quote: ... rhuIL-3 (1 ng/ml, R&D Systems). Erythropoiesis was induced by addition of 3 U/ml recombinant human erythropoietin (rEPO ...
-
bioRxiv - Microbiology 2022Quote: ... and cleaved-caspase-3 (AF835SP, R&D Systems) and β-actin as loading control (ab8226 ...
-
bioRxiv - Cancer Biology 2022Quote: ... Caspase 3 (R&D Systems AF835, 1:800). The sections were then incubated with appropriate secondary antibodies for 30 minutes at room temperature ...
-
bioRxiv - Neuroscience 2023Quote: ... 10 ng/ml Interleukin-3 (R&D Systems), 10 ng/ml Interleukin-6 (R&D Systems) ...
-
bioRxiv - Genomics 2023Quote: ... and NT-3 (20ng/ml, R&D Systems) every two days ...
-
bioRxiv - Bioengineering 2024Quote: ... and 3 mM CHIR99021 (R&D Systems; 4423).
-
bioRxiv - Bioengineering 2024Quote: ... and 3 mM CHIR99021 (R&D Systems; 4423). On day 7 ...
-
bioRxiv - Physiology 2019Quote: ... fully differentiated mouse or human brown adipocytes were incubated with 100ng/ml activin B (R&D Systems) in DMEM/F12 supplemented with 10% FBS and 100µg/ml penicillin-streptomycin for 24h before lysis and for RNA extraction of RNA (as indicated below) ...
-
bioRxiv - Microbiology 2020Quote: ... stimulated B cells were incubated with 20μg/ml anti–DC-SIGN mAb (clone 120507, R&D system) or mouse IgG (R & D Systems ...
-
bioRxiv - Cell Biology 2020Quote: ... Recombinant TGF-β1 (#240-B-002) and human growth hormone Genotropin (Pfizer) procured from R&D Systems.
-
bioRxiv - Molecular Biology 2022Quote: ... Human TGF-β1 (240-B) and IL-1β (201-LB-005) were purchased from R&D systems.
-
bioRxiv - Cancer Biology 2023Quote: ... Inhibitors used in the study are Recombinant Human TGF-β1 protein (R&D Systems, 240-B-002), SAHA (Sigma ...
-
bioRxiv - Cell Biology 2023Quote: ... TGF-β pathway was stimulated by adding rhTGF-β1 ligand (2ng/mL; R&D Systems; 240-B) for 24 hours ...
-
An endothelial SOX18-mevalonate pathway axis enables repurposing of statins for infantile hemangiomabioRxiv - Molecular Biology 2024Quote: ... The medium was replaced with fresh differentiation medium containing 10 ng/mL VEGF-B (R&D Systems) every two days ...
-
bioRxiv - Cell Biology 2023Quote: ... ascorbic acid and 40 ng/ml bFGF and VEGF (R&D Systems, MN). For single-cell RNA-seq ...
-
bioRxiv - Cancer Biology 2019Quote: ... 2×105 cells were cultured in CH12 medium supplemented with a mixture of IL4 (10 ng/mL, R&D Systems #404-ML-050, Minneapolis, MN, USA), TGFβ (1 ng/mL ...
-
bioRxiv - Immunology 2022Quote: ... NK cells were transferred to a round-bottom 96-well plate and resuspended in complete RPMI supplemented with 25 ng/mL rhIL-2 (R&D Systems, Cat. 202-IL-010). NK cells were then placed into a 37°C incubator ...
-
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccinebioRxiv - Immunology 2022Quote: ... there were six mice per treatment and control group for a total of 78 mice in thirteen groups: (A) Seven vaccine groups included 1 μg of unformulated SARS-CoV-2 spike protein (R&D Systems, Cat# 10549-CV-100) delivered with adjuvanted NPs ...
-
bioRxiv - Pathology 2020Quote: ... cells of 2 MOI were treated with serum-free media for 24 hours and then media containing TGF-β (20 ng/ml, R&D Systems, Minneapolis, MN, USA) for 72 hours ...
-
bioRxiv - Cancer Biology 2022Quote: ... Naïve CD8+ T cells were cultured in R10 media containing 5 ng/mL IL-7 (R&D systems). C57BL/6 CD8+ T cells were purified using the EasySep Mouse CD8 T Cell Isolation Kit (Stemcell technologies ...
-
bioRxiv - Cell Biology 2024Quote: ... cells were seeded at 1.5×105/ml in primary differentiation medium supplemented with 1ng/ml interleukin-3 (IL-3, R&D Systems), 10ng/ml SCF and 1μg/ml doxycycline ...
-
bioRxiv - Immunology 2022Quote: ... either alone or in combination with 1 μg/ml mouse IgG2 B anti-human TIGIT (R&D systems) or 1 μg/ml goat IgG anti-human TIM-3 (R&D systems ...
-
bioRxiv - Molecular Biology 2021Quote: ... Recombinant human TGFβ1 (100-B-001) and Thrombospondin-1 (3074-TH-050) were purchased from R&D Systems. Matrigel-based hydrogel culture system were employed ...
-
bioRxiv - Cancer Biology 2023Quote: ... granzyme B and IFN-γ secretion were measured using ELISA as described by the manufacturer (R&D Systems).
-
bioRxiv - Molecular Biology 2023Quote: Polystyrene microtiter plates were coated with 1 µg/ml recombinant SARS-CoV-2 spike protein produced in HEK293T cells (10549-CV-100, R&D Systems and Biotech, NE, MN, USA) while some plates were coated with 50 ng/ml SARS-CoV-2 S protein RBD or Biotinylated hACE2 (0.2 µg/ml ...
-
bioRxiv - Cancer Biology 2022Quote: ... the cells were starved with 2% FBS media overnight and treated with Activin-A (R&D system, 338-AC-010, 25 ng/mL or 50 ng/mL) for indicated times.
-
bioRxiv - Immunology 2023Quote: ... The remaining NK cells were transferred to a round-bottom 96-well plate and resuspended in complete RPMI supplemented with 25 ng/mL (250 IU/mL) rhIL-2 (R&D Systems, cat. no. 202-IL-010), then placed in a 37C CO2 incubator for 12-16 hours ...
-
bioRxiv - Immunology 2023Quote: ... the pellets obtained after centrifugation of the BAL fluid were pooled and stained for 30 min at 4°C with unconjugated polyclonal goat anti-mouse Ym1/2 (AF2446, R&D Systems; 1:100 diluted in PBS). After washing ...
-
bioRxiv - Microbiology 2021Quote: ... Cleaved caspase-3 was immunostained by incubating HAE with a primary human cleaved caspase-3 (Asp175) antibody (catalog no. MAB835; R&D Systems, Minneapolis ...
-
bioRxiv - Immunology 2020Quote: ... mouse or human T-cells were cultured with mouse or human IL-7 (10 ng/mL) (R&D Systems) or tacrolimus (Sigma-Aldrich) ...
-
bioRxiv - Developmental Biology 2022Quote: ... Explants were either treated with recombinant BMP2/7 heterodimers (32 nM, R&D Systems, Cat No. 3229-BM-010) or Noggin (300 ng/μl ...
-
bioRxiv - Microbiology 2021Quote: ... and IGFBP-3 DuoSet ELISA kit (R&D Systems), respectively ...
-
bioRxiv - Developmental Biology 2020Quote: ... Rabbit α-Active Caspase-3 (R&D Systems, #AF835), Mouse α-PAX7 (DSHB) ...
-
bioRxiv - Developmental Biology 2020Quote: ... supplemented with BMP4 (3 ng/ml, R&D Systems) and Thiazovivin (2 μM ...
-
bioRxiv - Synthetic Biology 2021Quote: ... and 3 μM GSK3 inhibitor (R&D Systems, CHIR99021). mESC medium was made from Knockout DMEM (Gibco 10829018) ...
-
bioRxiv - Immunology 2020Quote: ... LAG-3 (Polyclonal, R&D Systems, Minneapolis, MN, USA), CD123 (clone 7G3) ...
-
bioRxiv - Cancer Biology 2021Quote: ... active caspase-3 (R&D Systems AF835; 1:50), and Vimentin (CST 5741 ...
-
bioRxiv - Bioengineering 2021Quote: ... 20ng/mL IL-3 (R&D Systems 203-IL), 20 ng/mL G-CSF (R&D Systems 214-CS) ...
-
bioRxiv - Bioengineering 2021Quote: ... 0.01µg/mL IL-3 (R&D Systems, 203-IL) and 0.005µg/mL TNFα (R&D Systems ...
-
bioRxiv - Cell Biology 2021Quote: ... with 20 ng/ml rmIL-3 (R&D Systems), 50 ng/ml Flt3-Ligand (R&D Systems ...
-
bioRxiv - Genetics 2019Quote: ... and 3 μM GSK3 inhibitor (R&D Systems, CHIR99021). mESC medium was made from Knockout DMEM (Gibco 10829018) ...
-
bioRxiv - Cancer Biology 2020Quote: ... anti-cleaved caspase 3 were from R&D Systems.